• Ticker

DJIA 12,758.20 -132.26 -1.03%
NASDAQ 2,897.34 -29.89 -1.02%
S&P 500 1,338.81 -13.14 -0.97%
Maintenance Notification

Quotes and Portfolios will be down on Sunday February 12, 2012 from 2 AM to 4 AM while we perform maintenance on the site. We apologize for the inconvenience.

$16.42 -$0.93 (-5.36%)

Quote as of 3:27 PM EST on 02/10/12

Theravance, Inc.

NASDAQ:THRX

THRX vs. S&P 500
$16.42 -$0.93 (-5.36%)
Today's Open $16.61
Previous Close $17.35
Daily Range $15.69 - $16.85
52-Week Range $12.91 - $28.95
Market Cap $1.40B
P/E Ratio -12.31
Dividend (Yield) $0.00 (0.0%)
Volume 602,646
Average Daily Volume 753,568
Current FY EPS -$1.35

THRX Information

Description
A biopharmaceutical company focuses on the discovery, development and commercialization of small molecule medicines across a number of therapeutic areas including respiratory disease, bacterial infections and gastrointestinal motility dysfunction.
Sector
Healthcare
Industry
Biotechnology

News & Commentary

THRX's Top Competitors

THRX

$16.42 (-5.36%)

Current stock: THRX
AMGN

$67.17 (0.49%)

Current stock: AMGN
GILD

$53.64 (-0.17%)

Current stock: GILD
BIIB

$117.78 (0.00%)

Current stock: BIIB